Parallax Volatility Advisers, L.P. Viking Therapeutics, Inc. Transaction History
Parallax Volatility Advisers, L.P.
- $53.5 Billion
- Q3 2024
A detailed history of Parallax Volatility Advisers, L.P. transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 114,600 shares of VKTX stock, worth $6.25 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
114,600
Previous 51,200
123.83%
Holding current value
$6.25 Million
Previous $2.71 Million
167.32%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding VKTX
# of Institutions
474Shares Held
66.2MCall Options Held
5.72MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$554 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$328 Million0.01% of portfolio
-
State Street Corp Boston, MA4.67MShares$255 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.12MShares$115 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.87MShares$102 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $4.18B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...